Company profile

3D Medicines Inc.

1244 · HKEX (Listed on the HKEX Main Board since 2022-12-15 under ticker 1244 (company IR page, TradingView, CNBC, Bloomberg quote pages all confirm). Sources: https://clinicaltrials.gov/study/NCT05320809 Entity resolved by asset-pipeline-v2.)

Public Market Listing

1244HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for 3D Medicines Inc. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

0Phase 3 / Filed

1Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
3D189	Phase 1	WT1 (Wilms Tumor-1 protein)Peptide	Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.